FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Umbralisib (as umbralisib tosylate) 200 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Umbralisib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing lisocabtagene maraleucel (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lisocabtagene maraleucel only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lisocabtagene maraleucel-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lisocabtagene maraleucel only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 20 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ruxolitinib (as ruxolitinib phosphate) 15 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely olaparib 50 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ponatinib (as ponatinib hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely aflibercept 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely anagrelide (as anagrelide hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely eribulin (as eribulin mesilate) 440 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacomitinib 15 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacomitinib 30 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacomitinib 45 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely nilotinib (as nilotinib hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing idecabtagene vicleucel (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only idecabtagene vicleucel (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing idecabtagene vicleucel in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Idecabtagene vicleucel only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vemurafenib 240 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dostarlimab only product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dostarlimab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing dostarlimab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only dostarlimab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Imatinib (as imatinib mesilate) 50 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 168 mg/g cutaneous cream Plays role True Antineoplastic therapeutic role Inferred relationship Some
Loncastuximab tesirine-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only loncastuximab tesirine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing loncastuximab tesirine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Loncastuximab tesirine only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ibrutinib 140 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ibrutinib 420 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib 560 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ibrutinib 280 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely idelalisib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely lorlatinib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Lorlatinib 25 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dasatinib 100 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dasatinib 80 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely dasatinib 140 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing peginterferon beta-1a in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Peginterferon beta-1a only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a (as peginterferon beta-1a) 250 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Methotrexate (as methotrexate sodium) 2.5 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely methotrexate (as methotrexate sodium) 5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely methotrexate (as methotrexate sodium) 10 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely methotrexate (as methotrexate sodium) 15 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely methotrexate (as methotrexate sodium) 7.5 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Sotorasib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only sotorasib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely sotorasib 120 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only sotorasib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing sotorasib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Infigratinib-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only infigratinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Infigratinib-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Infigratinib only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely infigratinib 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Infigratinib 100 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Amivantamab-containing product Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only amivantamab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only amivantamab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Amivantamab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely lurbinectedin 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Mitomycin 5 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Abemaciclib 150 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely abemaciclib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely abemaciclib 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely encorafenib 75 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely encorafenib 50 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely trastuzumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nelarabine 5 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Nivolumab 10 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely osimertinib (as osimertinib mesilate) 80 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely osimertinib (as osimertinib mesilate) 40 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Methotrexate (as methotrexate sodium) 20 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely zanubrutinib 80 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely tivozanib (as tivozanib hydrochloride) 890 microgram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Melphalan flufenamide (as melphalan flufenamide hydrochloride) 20 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely mercaptopurine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely bendamustine hydrochloride 90 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely carboplatin 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cisplatin 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely oxaliplatin 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely etoposide 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Talazoparib (as talazoparib tosylate) 1 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Docetaxel 20 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Docetaxel 40 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacarbazine (as dacarbazine citrate) 100 mg powder for solution for injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Niraparib (as niraparib tosylate) 100 mg oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely talazoparib (as talazoparib tosylate) 250 microgram/1 each conventional release oral capsule (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon alfa-2a (as peginterferon alfa-2a) 180 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ifosfamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Blinatumomab 38.5 microgram powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 15 of 17 Next End

This concept is not in any reference sets

Back to Start